71 – 80 of 2256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
(
- Contribution to journal › Article
-
Mark
Future needs for continuing innovation in hemophilia : improving outcomes for individuals of all severities, including women and those in resource-constrained regions
(
- Contribution to journal › Scientific review
-
Mark
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
(
- Contribution to journal › Scientific review
-
Mark
SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
(
- Contribution to journal › Article
-
Mark
Morphological Clues of Acute Monocytic Leukemia in COVID-19-Induced Transient Leukoerythroblastic Reaction with Monocytosis
(
- Contribution to journal › Article
-
Mark
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma : A Danish observational population-based study
(
- Contribution to journal › Article
-
Mark
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial
(
- Contribution to journal › Article
-
Mark
MNS and Duffy Blood Group Systems
2024) p.127-130(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Immune thrombocytopenia : Pathophysiology and impacts of Romiplostim treatment
(
- Contribution to journal › Scientific review